Blog

Complete Guide to Supplement Stacks

Unfair Team • February 5, 2026

A supplement stack is a planned protocol: specific ingredients, doses, timing, and stop criteria chosen to change specific outcomes in a specific person, with a feedback loop that decides what stays, what goes, and what changes.

Most “stacks” fail because they are treated like a shopping list instead of an experiment.

Table of contents

SectionWhat you’ll get
What a supplement stack isA definition that prevents 80% of mistakes
Why stacks failThe failure modes that cause wasted money and avoidable risk
The stack-building processA complete workflow you can follow in one sitting
Decision rubricA way to choose candidates rationally, not by vibes
Stack templateFoundations vs modules, with evidence-strength labels
Dosing, timing, product selectionPractical dosing windows and quality checks
Running and iteratingBaseline periods, review cadence, washouts
MeasurementSimple metrics you can log consistently
SafetyContraindications, interaction categories, stop rules
Minimum viable stackStarting small without “doing nothing”
ExamplesComplete protocols for common goals
Using UnfairHow to implement the loop in the app without losing context

What a supplement stack is

A good stack has four properties.

It is goal-defined: you can name the outcome you want, the population you’re in, and how you’ll measure the outcome.

It is testable: you can plausibly detect the effect (or lack of effect) within a defined time window.

It is constrained: you can identify the likely risks and interactions up front, and you avoid unnecessary complexity.

It is revisable: it has a scheduled review, and decisions are based on logs, not memory.

If you want the beginner version of this workflow first, see Building Your First Supplement Stack.

Why stacks fail

Most failures are predictable. Fix these first and your odds of getting a real signal go up.

Failure mode: unclear objective. “More energy” can mean less sleep debt, better iron status, lower anxiety, higher carbohydrate intake, or just more caffeine. A supplement can’t be evaluated against a vague goal.

Failure mode: too many simultaneous changes. If you add six ingredients at once and you feel better (or worse), you learned nothing. N-of-1 trial methods exist because single-person experimentation can be done rigorously when changes are planned and measured.1

Failure mode: the outcome is not measurable. If your only metric is “how I feel this week,” noise wins. You need at least one stable subjective measure and one objective proxy you can collect repeatedly.

Failure mode: underdosing, overdosing, or mistiming. Many supplements have a narrow “effective dose range” and a specific time-to-effect. If you don’t know whether you should expect an acute effect (same day) or a slow effect (weeks), you’ll churn constantly.

Failure mode: hiding behind blends. Proprietary blends and “kitchen sink” pre-workouts often make it impossible to know what you took and at what dose. Some high-risk supplement categories have a long history of adulteration with unapproved drugs or drug analogs; when your stack depends on those categories, the risk profile changes dramatically.23

Failure mode: ignoring the real constraint: adherence. A theoretically perfect protocol that you follow 60% of the time loses to a good protocol you follow 95% of the time.

If you want a deeper classification of supplement types and risk tiers, see Understanding Supplement Categories.

The stack-building process

Use this as your default workflow. It’s conservative on purpose; you can speed it up later when you know how you respond.

PhaseWhat you doDefault durationWhat success looks like
BaselineKeep routines stable; log outcomes and confounders (sleep, training, caffeine, alcohol)14 daysYou have “normal variability” for your metrics
BuildChoose 1–2 foundation items + 1 goal module, using the rubric below30–60 minutesYou can explain why each ingredient is there
RampStart at the low end; increase only if needed and tolerated3–7 daysNo meaningful side effects; adherence >90%
RunHold everything steady; no “tinkering”14–42 days (depends on ingredient)Enough time to detect the expected effect
ReviewCompare to baseline; decide keep / adjust dose / adjust timing / removeEvery 2–4 weeksDecisions based on logs and predefined criteria
Optional washoutStop one ingredient at a time when attribution is unclear or side effects appear3–14+ days (depends)You can attribute benefits/harms more confidently

Decision rubric for picking candidates

This rubric forces you to answer the questions that matter: is there evidence for your outcome, is it safe for your situation, and can you actually test it?

Score each criterion from 0–2 (0 = no/poor, 1 = mixed/unclear, 2 = yes/strong). A “good bet” candidate usually scores 10+ and has no red-flag safety issues for you.

Criterion012What you’re looking for
Outcome matchNo direct link to your outcomeIndirect or mixed outcomesDirect evidence for your outcomeTrials that measure what you care about
Evidence qualityMostly anecdotes or animal dataSmall RCTs; inconsistentHigh-quality syntheses or large RCTsSystematic reviews; meta-analyses; guidelines
Effect size (typical)Tiny or unclearSmall but plausibleMeaningful and repeatableMagnitude you can detect in your life
Time-to-effectUnknownLong/variablePredictableYou know when to evaluate it
Safety for youHigh-risk or contraindicatedSome cautionsLow-risk in your contextYour meds, conditions, labs, history
Interaction loadMany likely interactionsSome possibleFew likelyEspecially stimulant and anticoagulant categories
PracticalityHard to source or takeMild hassleEasySimple schedule, tolerable form
TestabilityToo many confoundersSome confoundersClean testYou can hold other variables steady
Cost-effectivenessPoor ROIAcceptableHigh ROIYou’d pay for this signal

Stack template: foundation vs modules

A useful mental model is “stability first, then specificity.”

Foundations are about raising the floor: correcting likely gaps, reducing variance, and supporting the basics that make everything else work. Modules target a specific outcome with a defined evaluation window.

If you want a deeper “foundation-first” approach, see Supplement Foundations for Sustainable Results.

LayerWhat it’s forTypical candidates (examples, not requirements)Evidence strengthWhy that label
Foundation: adequacy and gapsFixing intake problems that masquerade as “needs a stack”Protein supplement to hit target intake; psyllium for soluble fiber; vitamin D only when deficient/high-risk; omega-3 when fish intake is lowStrong to ModerateProtein and fiber have consistent effects when intake is low; vitamin D benefits are concentrated in deficiency; omega-3 effects depend heavily on dose and endpoint4567
Foundation: performance basicsHigh-signal ergogenic support that’s easy to testCreatine monohydrate; caffeine (strategic)StrongRepeated findings across many RCTs and syntheses for performance outcomes; predictable dosing and timing8910
Module: sleep and circadianSleep onset, timing, and next-day functioningMelatonin (timed for sleep onset/circadian shift); magnesium (if low intake/constipation); glycine (small trials)Moderate to LimitedMelatonin shows modest but consistent changes in sleep-onset metrics; magnesium and glycine evidence is narrower and more heterogeneous111213
Module: focus and mental energyAcute attention/alertness with less jitterCaffeine + L-theanineModerateTask-specific benefits with mixed study designs; more consistent for attention-switching and reaction-time tasks than for broad “productivity”1415
Module: stress resilienceSubjective stress/anxiety measures (not “life transformation”)Ashwagandha extracts (standardized)Limited to ModerateMeta-analyses suggest improvements in stress/anxiety and cortisol, but many trials are small; product heterogeneity matters1617
Module: endurance and high-intensity workTime-to-exhaustion, time-trial, repeated boutsDietary nitrate (beetroot); beta-alanineModerateEffects are usually small and context-dependent; strongest for specific durations/intensities; require correct dosing/time frame1819
Module: joints/tendonsPain/function with training, connective tissue supportCollagen peptides (often paired with training)LimitedSome trials show modest pain/function changes; evidence varies by population and outcome20

A practical rule: never add a module until your foundation is stable enough that you can notice a change.

Dosing, timing, and product selection

“Correct” dosing is less about the perfect milligram and more about matching the dosing strategy to the expected biology, then making adherence automatic.

Dosing strategy: acute vs chronic

Acute supplements are evaluated on the same day or within a few days because the effect is immediate and reversible. Caffeine is the obvious example; performance effects are commonly seen with moderate doses (often 3–6 mg/kg) taken pre-exercise, with typical improvements in endurance metrics on the order of a few percent in meta-analytic summaries.10

Chronic supplements need saturation or remodeling. Creatine typically needs weeks for full effect in many contexts; protein and fiber change outcomes on the scale of weeks; omega-3 changes tissue levels over longer horizons and is easiest to evaluate against lipids or inflammation proxies you can actually measure.48

Make timing boring

Your schedule should minimize decision points. “Boring” stacks get followed.

Timing windowWhat usually fits hereWhat to avoid hereWhy
MorningFoundation items that don’t affect sleep; fiber with water; omega-3 with foodNew stimulants if you’re also testing sleepMorning is a consistent anchor; reduces missed doses
Pre-training (30–180 min)Caffeine; nitrates (often earlier); creatine is not time-criticalMultiple overlapping stimulantsPre-workout is where stacks accidentally become stimulant cocktails
EveningSleep module trials (melatonin timed; glycine; magnesium if tolerated)Anything that can increase arousalKeeps sleep experiments clean
With mealsFat-soluble vitamins; omega-3; magnesium (if GI tolerance)Fiber too close to medsFood can improve tolerability; fiber can reduce absorption of some meds

Product quality is part of dose

Supplements are not approved by the FDA for safety or effectiveness before they are sold; manufacturers are responsible for ensuring products meet legal standards, and enforcement is largely post-market.21 That matters more when you stack multiple products.

Practical quality checks that change your risk, not just your feelings:

Third-party verification for identity/purity and label accuracy. Programs such as USP’s Dietary Supplement Verification Program and NSF Certified for Sport exist because label accuracy and contamination are real failure modes.2223

If you are drug-tested or compete, treat supplements as a doping risk category. Even well-meaning products can be contaminated; certification reduces risk, it does not eliminate it.2423

Avoid proprietary blends for anything you want to test. If the label won’t tell you the dose, you can’t run a protocol.

Avoid “grey-zone stimulant” products. The FDA has warned about DMAA (1,3-dimethylamylamine) being marketed in supplements and about health risks, especially when combined with other stimulants like caffeine.25

Run it like an experiment: baseline, ramp, review, washout

If you want “results without hype,” you need a loop that protects you from motivated reasoning.

Baseline: establish your noise floor

A baseline is not a formality. It tells you what “normal variability” looks like so you don’t mistake regression-to-the-mean for a supplement effect.

Baseline log minimum: your target metrics (subjective + objective), sleep, training, caffeine, alcohol, and anything that predictably changes your outcome (travel, illness).

Ramp: start low, then earn dose increases

The goal of a ramp is not to “feel it.” It’s to find the lowest dose that produces a measurable benefit without side effects.

Many side effects are dose-dependent and non-informative (they tell you you took something, not that it worked). Beta-alanine tingles are the classic example; splitting doses and using sustained-release forms can reduce paresthesia while maintaining the intended chronic effect.19

Review cadence: pick a calendar day

Memory is the enemy. Pick a review cadence that matches time-to-effect.

Acute modules (caffeine/theanine, nitrates): you can review weekly because you get repeated trials.

Chronic modules (creatine, beta-alanine, fiber): review every 3–6 weeks, because effect sizes emerge slowly and noise is high week-to-week.

Washout: use it when attribution matters

Washouts are not required for every decision. Use them when:

You have side effects and need to identify the cause.

You have a benefit but can’t tell which ingredient produced it.

You’re simplifying the stack (often the best “upgrade”).

Default washout guidance is about biology, not ideology. Some effects reverse quickly; others are slow to clear.

Ingredient typeExamplesWhen you can expect effectsWhen you can expect reversal after stopping (typical)Why
Acute stimulantCaffeineSame dayDays (withdrawal possible)Fast pharmacology; tolerance/withdrawal complicate interpretation1026
Acute nitric oxide supportNitrates (beetroot)Same day (with correct timing)DaysEffect is tied to intake and oral microbiome; timing matters18
Tissue saturationCreatineWeeksWeeksMuscle creatine stores change gradually; evaluate on longer windows8
Buffering adaptationBeta-alanineWeeksWeeksCarnosine increases over time and decays over time19
Circadian signalMelatoninSame day to weeks (timing-dependent)DaysTiming drives circadian effect; keep schedule stable1127
Fiber/metabolicPsylliumDays to weeksDays to weeksChanges stool/LDL metrics over time; adherence is the limiter6

Measurement that you’ll actually do

A stack is only as good as its measurement. Your goal is not perfect data; your goal is data that changes decisions.

Separate outcomes into three buckets

Primary outcome: the reason you’re doing this. One metric.

Secondary outcomes: what you hope changes but can’t make the whole project about. Two to four metrics.

Safety/tolerability: what would make you stop. Always tracked.

Use both subjective and objective proxies

Subjective measures are legitimate, but they need structure. A daily 1–10 rating with an anchor description is far better than “felt good.”

Objective proxies keep you honest, but only if you’ll collect them.

Examples that people actually sustain:

Sleep: sleep onset latency (minutes); total sleep time; subjective sleep quality (1–10); morning sleepiness (1–10); wearable-derived sleep timing if you have it.

Focus: timed deep-work blocks completed; distraction count (simple tally); reaction-time test if you’ll repeat it.

Training: session RPE; total volume for key lifts; time-trial completion time; repeated sprint output.

Metabolic: fasting weight trend (weekly average); waist circumference (weekly); lipids/glucose only if you will test in a consistent way (ideally through a clinician).

Iteration log template

Use this table as your weekly review record. The point is to preserve context so you stop re-running the same experiment forever.

WeekStack versionChange madeAdherence (%)Primary outcome (avg)Secondary outcomesSide effects / safety notesConfounders (travel, illness, alcohol, training changes)Decision
0 (baseline)NoneNone-Start trial
1
2
3
4

Safety: interactions, contraindications, stop criteria

A “safe stack mindset” is not fear. It’s operational clarity: you know what would make you stop and when you should involve a clinician.

High-yield interaction categories

This table is not exhaustive. It is the set of interaction categories that commonly matter in real life stacks.

CategoryWhy it mattersCommon stack ingredients that trigger cautionTypical mitigation
Stimulants and sympathomimeticsAdditive heart rate, blood pressure, anxiety, sleep disruptionCaffeine; stimulant pre-workouts; DMAA-like productsKeep stimulant count low; dose earlier; avoid grey-zone stimulants1025
Anticoagulants/antiplateletsBleeding risk and procedural risk; monitoring changesHigh-dose omega-3; some herbal productsClinician review if you’re on anticoagulants; avoid “random herbs” stacking428
Sedatives and CNS depressantsAdditive sedation, impaired driving, next-day grogginessMelatonin; high-dose magnesium; combined “sleep blends”Start low; single ingredient trials; stop if next-day impairment1112
Thyroid and endocrine-sensitive contextsSome botanicals may affect thyroid hormones or symptomsAshwagandha (case reports and mechanistic concerns)Avoid if thyroid disease unless supervised; stop if symptoms shift1629
Antibiotics/bisphosphonates absorptionMinerals can reduce absorption of some medsMagnesium; iron; calciumSeparate dosing by hours; follow clinician/pharmacist advice12
Lab test interferenceSupplements can distort labs and clinical decisionsBiotin (common in “hair/skin/nails” products)Tell clinician; pause biotin before relevant tests per guidance30

Stop criteria (use these)

Stop criteria are not moral judgments; they are pre-commitments that prevent escalation.

Stop immediately and reassess if you get: chest pain; fainting; severe palpitations; severe shortness of breath; signs of allergic reaction; severe mood changes; jaundice or dark urine after starting a botanical.

Stop and simplify (remove the most recent change first) if you see: persistent insomnia; anxiety increase; GI distress that disrupts life; headaches that correlate with dosing; a sustained adverse change in your primary metric.

If you are taking prescription medications, are pregnant/breastfeeding, have kidney or liver disease, have a history of bipolar disorder/psychosis, have arrhythmias, or you’re managing a chronic condition, involve a clinician before running multi-ingredient stacks. The cost is usually one visit; the benefit is avoiding the “stack as uncontrolled polypharmacy” problem.

A note on “safe” categories

Some supplement categories are structurally higher risk because of adulteration incentives and historical patterns: sexual enhancement, rapid weight loss, and some bodybuilding/pre-workout products. The FDA has repeatedly issued warnings and recalls for products tainted with unapproved drugs (for example, PDE-5 inhibitor ingredients in “male enhancement” products).331 If your stack depends on these categories, your safety model should change.

Minimum viable stack: earn complexity

The minimum viable stack is the smallest set of changes that can plausibly move your outcomes while keeping attribution and safety manageable.

A good minimum viable stack usually looks like one foundation plus one module, not five “essentials.”

Minimum viable stack options

GoalMinimum viable stackEvidence strengthWhat makes it “minimum viable”
General training supportCreatine monohydrate daily; optional caffeine only on key sessionsStrongTwo ingredients with predictable effects and easy measurement810
Sleep onset and scheduleTimed melatonin (lowest effective dose)ModerateSingle ingredient with measurable outcomes and clear stop rules1127
Cholesterol support (non-drug adjunct)Psyllium daily with waterModerate to StrongDose-dependent LDL reduction; easy adherence and measurement if you have labs632
Stress resilienceStandardized ashwagandha extract trialLimited to ModerateA single botanical with measurable subjective outcomes; requires stricter stop rules1629

Example stacks: complete protocols

These examples are meant to be realistic and conservative. They are not maximal. They are designed to teach the process: who fits, who should avoid, what to track, and how to iterate.

Example: Focus and deep work with fewer jitters

Evidence strength Moderate. Caffeine reliably improves alertness and performance; combining with L-theanine appears to improve attention-switching and reduce distraction in some tasks, with effects that are task-specific and not universal.101415

Fits People who want acute focus for cognitively demanding work; people who tolerate caffeine but dislike jitters.

Avoid if Pregnancy; uncontrolled hypertension; arrhythmias; panic disorder that flares with stimulants; insomnia that is not already controlled.

Protocol (starting ranges)

IngredientConservative starting rangeTiming windowNotes
Caffeine50–100 mg (or ~1 mg/kg)30–60 min before work blockIncrease only if needed; avoid late-day dosing1026
L-theanine100–200 mgWith caffeineOften tested at ~100 mg theanine with ~50 mg caffeine in trials14

What to track Number of uninterrupted work blocks completed; distraction count; subjective focus (1–10); sleep onset latency that night.

First change if it fails Reduce caffeine dose and move it earlier; if still jittery, keep caffeine fixed and test higher theanine within conservative bounds; if focus is unchanged, stop and reassess whether sleep debt, nutrition, or workload design is the real constraint.

Stop criteria Persistent anxiety, tremor, palpitations, or sleep disruption lasting more than three days at the same dose.

Example: Strength and hypertrophy support (non-stimulant core)

Evidence strength Strong for creatine; Strong to Moderate for protein supplementation when it helps you hit total protein targets.894

Fits People doing progressive resistance training; people who are inconsistent on protein intake; older adults looking for a low-risk performance foundation.

Avoid if Known kidney disease without clinician guidance; anyone who cannot tolerate water-weight changes (for example, weight-class sport close to competition).

Protocol (starting ranges)

IngredientConservative starting rangeTiming windowNotes
Creatine monohydrate3 g/dayAny time dailyTiming is not critical; consistency is89
Protein supplement (if needed)20–40 g per servingAs needed to reach daily targetTotal protein intake and distribution matter more than a specific product45

What to track Training volume and/or estimated 1RM trends; body weight (weekly average); GI tolerance; subjective recovery.

First change if it fails If strength is not moving, the first “stack change” is usually not a supplement; it’s training progression or total calories. If training is progressing but recovery is poor, verify sleep and total protein intake before adding more ingredients.

Stop criteria New GI distress that disrupts training; new swelling/edema not explained by creatine water weight; any lab abnormalities discussed with a clinician (note that creatine can raise serum creatinine without harming GFR in many contexts, which can confuse interpretation).33

Example: Sleep onset and circadian alignment

Evidence strength Moderate for melatonin on sleep onset latency and circadian timing; Limited for add-ons like glycine unless you respond clearly.111327

Fits Difficulty falling asleep at a consistent time; jet lag or shifted schedules; people who want to reduce sleep-onset latency without heavy sedatives.

Avoid if Pregnancy/breastfeeding; epilepsy meds or anticoagulants without clinician guidance; autoimmune disease flares you’re monitoring closely; anyone with a history of worsening mood symptoms with sleep agents.

Protocol (starting ranges)

IngredientConservative starting rangeTiming windowNotes
Melatonin0.3–1 mg1–3 hours before target bedtimeTiming matters; higher doses are not always better1127
Optional glycine (trial)3 g30–60 min before bedSmall trials suggest subjective sleep improvements; treat as experimental add-on13

What to track Sleep onset latency; total sleep time; next-day sleepiness; vivid dreams/nightmares; morning grogginess.

First change if it fails Adjust timing before changing dose. For many people, timing is the whole intervention. If timing changes do nothing, stop and shift attention to light exposure, caffeine timing, and bedtime behavior; supplements are weak against strong circadian inputs.

Stop criteria Next-day impairment; mood changes; persistent abnormal dreams; any concerning symptoms. If you use melatonin, consider product quality: analyses have found large variability in labeled vs measured melatonin content and occasional serotonin contamination in commercial products, which makes third-party testing materially relevant.34

Example: Stress resilience (measurable, not magical)

Evidence strength Limited to Moderate. Meta-analyses suggest reductions in stress/anxiety measures and cortisol, but trials are often small and products vary; rare liver injury case reports exist, which changes stop criteria.161729

Fits People with elevated perceived stress who want a structured trial; people who can track anxiety/stress scores consistently.

Avoid if Liver disease; thyroid disease; autoimmune disease; pregnancy/breastfeeding; concurrent sedative use without clinician guidance.

Protocol (starting ranges)

IngredientConservative starting rangeTiming windowNotes
Ashwagandha (standardized extract)250–600 mg/day (per product standardization)With food; split dose if neededChoose a standardized extract with clear dosing; avoid “mystery blends”1617

What to track Daily stress rating (1–10) with a written anchor; anxiety symptoms; sleep quality; GI symptoms; any signs of jaundice or dark urine.

First change if it fails If no change after 4–6 weeks with good adherence, stop. If partial benefit with sedation, reduce dose or move earlier in the day.

Stop criteria Any signs of liver injury (jaundice, dark urine, intense itching, right upper abdominal pain), severe GI symptoms, or worsening mood. Case reports describe cholestatic liver injury patterns after ashwagandha in some individuals; treat this as a real stop condition, not internet drama.29

Example: Endurance or hard intervals (small edges, correct timing)

Evidence strength Moderate. Dietary nitrate tends to help certain endurance or high-intensity efforts, especially in the ~2–10 minute range; beta-alanine has more consistent value for repeated high-intensity efforts over weeks, with small-to-moderate effects depending on protocol.1819

Fits People doing interval work or time-trials who can repeat similar sessions; athletes who want a measurable performance edge without stacking stimulants.

Avoid if Use of PDE-5 inhibitors or nitrate medications; low blood pressure; significant GI sensitivity.

Protocol (starting ranges)

IngredientConservative starting rangeTiming windowNotes
Dietary nitrate (beetroot)Product-specific dose; aim for studied nitrate range (often ~5–9.9 mmol/day in multi-day protocols)Often ~2–3 hours pre-sessionAvoid antiseptic mouthwash around dosing; oral bacteria matter18
Beta-alanine3.2–6.4 g/day (split doses)Daily for 4+ weeksSplit dosing reduces tingles; expect slow onset19

What to track Performance on a repeatable session (time-trial time, average power, interval completion); GI tolerance; perceived exertion; sleep if dosing includes stimulants (it doesn’t need to).

First change if it fails Fix timing for nitrate before changing dose; if nitrate is inconsistent, drop it and keep beta-alanine for a longer run; if beta-alanine side effects are bothersome, lower dose and split further.

Stop criteria Hypotension symptoms, severe headaches, severe GI symptoms.

Running the loop in Unfair

The hard part of stacking is not knowledge; it’s execution and recall.

A practical way to implement this workflow in Unfair:

Convert a recommendation bundle into an active stack so the “protocol version” is explicit.

Schedule doses as events tied to your real anchors (wake time, first meal, training window, bedtime) so adherence is automatic.

Log each dose event and add a short note only when something changes (symptom shift, side effect, travel, poor sleep). This keeps the data sparse but decision-relevant.

Run a weekly review note that mirrors the iteration log table: adherence, primary outcome trend, confounders, and the decision. When you revise the stack, you preserve the full history instead of restarting from scratch.

This loop stays useful even if you never touch wearables or lab tests, because it forces consistent inputs and honest review.

References

This article is for education and should be used with clinician guidance when you have medical conditions, take prescription medications, or are pregnant/breastfeeding.


  1. Vohra S, Shamseer L, Sampson M, et al. (CENT Group). CONSORT extension for reporting N-of-1 trials (CENT) 2015 Statement. 2015. BMJ. https://www.bmj.com/content/350/bmj.h1738

  2. Tucker J, Fischer T, Upjohn L, Mazzera D, Kumar M. Unapproved Pharmaceutical Ingredients Included in Dietary Supplements Associated With US Food and Drug Administration Warnings. 2018. JAMA Network Open. https://pmc.ncbi.nlm.nih.gov/articles/PMC6324457/

  3. U.S. Food and Drug Administration. One Source Nutrition, Inc. Issues Voluntary Nationwide Recall of Vitality Capsules Due to Presence of Undeclared Sildenafil and Tadalafil. 2025. FDA Safety Alerts/Recalls. https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/one-source-nutrition-inc-issues-voluntary-nationwide-recall-vitality-capsules-due-presence

  4. Morton RW, Murphy KT, McKellar SR, et al. A systematic review, meta-analysis and meta-regression of the effect of protein supplementation on resistance training-induced gains in muscle mass and strength in healthy adults. 2018. Br J Sports Med. https://pubmed.ncbi.nlm.nih.gov/28698222/

  5. Jäger R, Kerksick CM, Campbell BI, et al. International Society of Sports Nutrition Position Stand: protein and exercise. 2017. J Int Soc Sports Nutr. https://www.tandfonline.com/doi/full/10.1186/s12970-017-0177-8

  6. Gholami Z, et al. Psyllium supplementation and lipid profiles: systematic review and meta-analysis. 2025. (Full text via PubMed Central). https://pmc.ncbi.nlm.nih.gov/articles/PMC12690803/

  7. Bouillon R, et al. Health effects of vitamin D supplementation: evidence from randomized controlled trials and Mendelian randomization studies. 2023. (Review; full text via PubMed Central). https://pmc.ncbi.nlm.nih.gov/articles/PMC10592274/

  8. Kreider RB, Kalman DS, Antonio J, et al. International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. 2017. J Int Soc Sports Nutr. https://www.tandfonline.com/doi/full/10.1186/s12970-017-0173-z

  9. Zhang H, et al. Effects of creatine supplementation on muscle strength gains: systematic review and meta-analysis. 2025. (Full text via PubMed Central). https://pmc.ncbi.nlm.nih.gov/articles/PMC12665265/

  10. Guest NS, VanDusseldorp TA, Nelson MT, et al. International Society of Sports Nutrition position stand: caffeine and exercise performance. 2021. J Int Soc Sports Nutr. https://pmc.ncbi.nlm.nih.gov/articles/PMC7777221/

  11. Ferracioli-Oda E, Qawasmi A, Bloch MH. Meta-analysis: Melatonin for the treatment of primary sleep disorders. 2013. PLoS One. https://pmc.ncbi.nlm.nih.gov/articles/PMC3656905/

  12. National Institutes of Health, Office of Dietary Supplements. Magnesium: Health Professional Fact Sheet. Updated 2026. https://ods.od.nih.gov/factsheets/Magnesium-HealthProfessional/

  13. Soh J, et al. The effect of glycine administration on the characteristics of sleep and its mechanism: a review. 2023. (Review; full text via PubMed Central). https://pmc.ncbi.nlm.nih.gov/articles/PMC10828290/

  14. Owen GN, Parnell H, De Bruin EA, Rycroft JA. The combined effects of L-theanine and caffeine on cognitive performance and mood. 2008. Nutritional Neuroscience. https://pubmed.ncbi.nlm.nih.gov/18681988/

  15. Payne ER, et al. Effects of Tea (Camellia sinensis) or its Bioactive Compounds on Cognitive Performance: A Systematic Review and Meta-analysis. 2025. Nutrition Reviews. https://academic.oup.com/nutritionreviews/article/83/10/1873/8123998

  16. National Institutes of Health, Office of Dietary Supplements. Ashwagandha: Health Professional Fact Sheet. 2025. https://ods.od.nih.gov/factsheets/Ashwagandha-HealthProfessional/

  17. Akhgarjand C, et al. Does Ashwagandha supplementation have a beneficial effect on stress and anxiety? Systematic review and dose-response meta-analysis of randomized controlled trials. 2022. (PubMed record). https://pubmed.ncbi.nlm.nih.gov/36017529/

  18. Silva KVC, et al. Factors that Moderate the Effect of Nitrate Ingestion on Exercise Performance: Systematic Review and Meta-analysis. 2022. The American Journal of Clinical Nutrition. https://www.sciencedirect.com/science/article/pii/S2161831323000455

  19. Saunders B, et al. β-alanine supplementation to improve exercise capacity and performance: a systematic review and meta-analysis. 2017. Br J Sports Med. https://pubmed.ncbi.nlm.nih.gov/27797728/

  20. Khatri M, et al. The effects of collagen peptide supplementation on body composition, muscle soreness, and damage following exercise: a systematic review. 2021. (Full text via PubMed Central). https://pmc.ncbi.nlm.nih.gov/articles/PMC8521576/

  21. U.S. Food and Drug Administration. FDA 101: Dietary Supplements. 2022. https://www.fda.gov/consumers/consumer-updates/fda-101-dietary-supplements

  22. U.S. Pharmacopeia (USP). Dietary Supplement Verification Program. https://www.usp.org/verification-services/dietary-supplements-verification-program

  23. NSF. Certified for Sport® Program. https://www.nsf.org/consumer-resources/articles/certified-for-sport-program

  24. International Testing Agency (ITA). Supplements. https://ita.sport/athlete-hub/supplements/

  25. U.S. Food and Drug Administration. DMAA in Products Marketed as Dietary Supplements. 2023. https://www.fda.gov/food/information-select-dietary-supplement-ingredients-and-other-substances/dmaa-products-marketed-dietary-supplements

  26. U.S. Food and Drug Administration. Spilling the Beans: How Much Caffeine is Too Much? 2024. https://www.fda.gov/consumers/consumer-updates/spilling-beans-how-much-caffeine-too-much

  27. Auger RR, Burgess HJ, Emens JS, et al. Clinical practice guideline for the treatment of intrinsic circadian rhythm sleep-wake disorders: an update for 2015. 2015. J Clin Sleep Med. https://pmc.ncbi.nlm.nih.gov/articles/PMC4582061/

  28. National Institutes of Health, Office of Dietary Supplements. Omega-3 Fatty Acids: Health Professional Fact Sheet. https://ods.od.nih.gov/factsheets/Omega3FattyAcids-HealthProfessional/

  29. Lubarska M, et al. A Case Report of Ashwagandha-Induced Liver Injury. 2023. (Full text via PubMed Central). https://pmc.ncbi.nlm.nih.gov/articles/PMC10002162/

  30. U.S. Food and Drug Administration. Biotin Interference with Troponin Lab Tests (Assays Subject to Biotin Interference). 2022. https://www.fda.gov/medical-devices/in-vitro-diagnostics/biotin-interference-troponin-lab-tests-assays-subject-biotin-interference

  31. Tucker J, Fischer T. Unapproved Pharmaceutical Ingredients Included in Dietary Supplements Associated With US Food and Drug Administration Warnings. 2018. JAMA Network Open. https://pmc.ncbi.nlm.nih.gov/articles/PMC6324457/

  32. Chen C, et al. Beneficial effects of psyllium on the prevention and treatment of obesity and metabolic syndrome: mechanisms and clinical evidence. 2022. Food & Function (Royal Society of Chemistry). https://pubs.rsc.org/en/content/articlehtml/2022/fo/d2fo00560c

  33. Naeini EK, et al. Effect of creatine supplementation on kidney function: systematic review and meta-analysis. 2025. (Full text via PubMed Central). https://pmc.ncbi.nlm.nih.gov/articles/PMC12590749/

  34. Erland LAE, Saxena PK. Melatonin natural health products and supplements: presence of serotonin and significant variability of melatonin content. 2017. J Clin Sleep Med. https://pmc.ncbi.nlm.nih.gov/articles/PMC5263083/

Related

Building Your First Supplement Stack

Build stacks like experiments: pick one goal, change one variable at a time, and keep only what produces a meaningful, repeatable benefit at a risk level you accept.

Supplement Foundations for Sustainable Results

A foundation stack is not "take everything that might help." It is a short list of supplements that correct probable gaps in your intake and stabilize the basics (sleep, recovery, energy) so you have a clean baseline for testing anything more specific later.

Understanding Supplement Categories

Every supplement in your stack should have a defined role